Swiss Life Asset Management Ltd Has $2.70 Million Holdings in Healthpeak Properties, Inc. $DOC

Swiss Life Asset Management Ltd grew its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 41.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 167,828 shares of the real estate investment trust’s stock after acquiring an additional 49,025 shares during the period. Swiss Life Asset Management Ltd’s holdings in Healthpeak Properties were worth $2,699,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. CoreCap Advisors LLC raised its stake in shares of Healthpeak Properties by 22.4% in the third quarter. CoreCap Advisors LLC now owns 3,352 shares of the real estate investment trust’s stock worth $64,000 after acquiring an additional 613 shares during the last quarter. Fiduciary Trust Co raised its stake in shares of Healthpeak Properties by 4.9% in the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after acquiring an additional 644 shares during the last quarter. Patton Fund Management Inc. raised its stake in shares of Healthpeak Properties by 5.2% in the fourth quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after acquiring an additional 648 shares during the last quarter. Arjuna Capital raised its stake in shares of Healthpeak Properties by 4.8% in the third quarter. Arjuna Capital now owns 14,768 shares of the real estate investment trust’s stock worth $283,000 after acquiring an additional 679 shares during the last quarter. Finally, Quadrant Capital Group LLC raised its stake in shares of Healthpeak Properties by 1.9% in the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock worth $721,000 after acquiring an additional 718 shares during the last quarter. 93.57% of the stock is owned by institutional investors.

Insider Buying and Selling at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares in the company, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.23% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have weighed in on DOC shares. Morgan Stanley dropped their target price on shares of Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating for the company in a research note on Tuesday, April 28th. Scotiabank raised shares of Healthpeak Properties to a “hold” rating in a research note on Thursday, April 23rd. Robert W. Baird boosted their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a research note on Wednesday. Wall Street Zen raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Finally, Weiss Ratings raised shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Five investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Hold” and a consensus price target of $18.92.

Healthpeak Properties Trading Down 0.1%

DOC opened at $19.53 on Friday. The company has a market cap of $13.46 billion, a price-to-earnings ratio of 61.02, a price-to-earnings-growth ratio of 2.70 and a beta of 1.00. The firm has a 50 day simple moving average of $17.23 and a 200 day simple moving average of $17.19. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $19.91.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The firm had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.74 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be issued a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 6.2%. The ex-dividend date is Monday, June 15th. Healthpeak Properties’s dividend payout ratio is 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.